Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function

NCT02584075 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Coronary Endothelial Function

Interventions

DRUG: Byetta (Exenatide)
DRUG: Glucophage ( Metformin Hydrochloride)

Sponsor

Beijing Chao Yang Hospital